EMR vs PH
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 04, 2026
EMR
PH
Investment Advisor Scores
PH
AI Analyst Insights
Detailed Metrics Comparison
| Metric | EMR | PH | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 20.8768 | 28.6533 | EMR |
| PEG Ratio | 2.0895 | 3.8183 | EMR |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 2.9% | 10.6% | PH |
| Earnings Growth | 27.9% | -4.2% | EMR |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 52.2/100 | 52.8/100 | PH |
| Profit Margin | 13.4% | 16.6% | PH |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
EMR
MarkupPrice above SMA50, rising 50-day trend (1.6% over 20 days), RSI 69
PH
MarkupPrice above SMA50, rising 50-day trend (3.3% over 20 days), RSI 61
Fundamentals Snapshot
| Metric | EMR | PH |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 21.6 | 29.2 |
| Trailing P/E | 34.8 | 36.0 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.1% |
| Gross Margin | 0.5% | 0.4% |
| Operating Margin | 0.2% | 0.2% |
| EPS | 4.31 | 27.15 |
| Dividend Yield | 0.01% | 0.01% |